Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GKL-006RTU in Moderate to Severe ARDS
NCT07706855Phase 2Not yet recruiting
- Sponsor
- GenePlus
- Start
- Nov 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of GKL-006RTU in acute respiratory distress syndrome (ARDS), sponsored by GenePlus. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
GKL-006RTU
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07706855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706855.